{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:00:30Z","timestamp":1791925230585,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the project was supported by OP2 Drugs, Pessac, France","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10557-020-07113-7","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T07:53:17Z","timestamp":1612857197000},"page":"217-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia\/Reperfusion Model"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4797-0138","authenticated-orcid":false,"given":"Wangde","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivea Dias","family":"Amoedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Le Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Boucard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Carreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigue","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"issue":"22","key":"7113_CR1","doi-asserted-by":"publisher","first-page":"e012054","DOI":"10.1161\/JAHA.119.012054","volume":"8","author":"H Han","year":"2019","unstructured":"Han H, Wei X, He Q, Yu Y, Ruan Y, Wu C, et al. Comparison of in-hospital mortality and length of stay in acute ST-segment-elevation myocardial infarction among urban teaching hospitals in China and the United States. J Am Heart Assoc. 2019;8(22):e012054.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"7113_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","volume":"6","author":"MC Bahit","year":"2018","unstructured":"Bahit MC, Ajar Kochar A, Granger CB. Post-myocardial infarction heart failure. JACC Heart Fail. 2018;6(3):179\u201386.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"7113_CR3","doi-asserted-by":"publisher","first-page":"e0216385","DOI":"10.1371\/journal.pone.0216385","volume":"14","author":"D Detaille","year":"2019","unstructured":"Detaille D, Pasdois P, S\u00e9mont A, Santos PD, Diolez P. An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals. PLoS One. 2019;14(5):e0216385.","journal-title":"PLoS One"},{"key":"7113_CR4","doi-asserted-by":"publisher","unstructured":"Amoedo ND, Dard L, Sarlak S, Mahfouf W, Blanchard W, Rousseau B, et al. Targeting human lung adenocarcinoma with a suppressor of mitochondrial superoxide production. Antioxid Redox Signal. 2020. https:\/\/doi.org\/10.1089\/ars.2019.7892 Online ahead of print.","DOI":"10.1089\/ars.2019.7892"},{"issue":"5","key":"7113_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.yjmcc.2012.02.009","volume":"52","author":"RC Sloan","year":"2012","unstructured":"Sloan RC, Moukdar F, Frasier CR, Patel HD, Bostian PA, Lust RM, et al. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury. J Mol Cell Cardiol. 2012;52(5):1009\u201318.","journal-title":"J Mol Cell Cardiol"},{"key":"7113_CR6","volume-title":"Mitochondrial pathways and respiratory control. An introduction to OXPHOS analysis","author":"E Gnaiger","year":"2014","unstructured":"Gnaiger E. Mitochondrial pathways and respiratory control. An introduction to OXPHOS analysis. 4th ed. Innsbruck: Oroboros MiPNet Publications; 2014. www.bioblast.at\/index.php\/Gnaiger_2014_MitoPathways","edition":"4"},{"key":"7113_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0021-9258(19)57189-7","volume":"217","author":"B Chance","year":"1955","unstructured":"Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. J Biol Chem. 1955;217:383\u201393.","journal-title":"J Biol Chem"},{"key":"7113_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/biom5031319","volume":"5","author":"M Makrecka-Kuka","year":"2015","unstructured":"Makrecka-Kuka M, Krumschnabel G, Gnaiger E. High-resolution respirometry for simultaneous measurement of oxygen and hydrogen peroxide fluxes in permeabilized cells, tissue homogenate and isolated mitochondria. Biomolecules. 2015;5:1319\u201338.","journal-title":"Biomolecules"},{"issue":"10","key":"7113_CR9","doi-asserted-by":"publisher","first-page":"H1360","DOI":"10.1152\/ajpheart.00858.2015","volume":"310","author":"RJ Alleman","year":"2016","unstructured":"Alleman RJ, Tsang AM, Ryan TE, Patteson DJ, McClung JM, Spangenburg EE, et al. Exercise-induced protection against reperfusion arrhythmia involves stabilization of mitochondrial energetics. Am J Physiol Heart Circ Physiol. 2016;310(10):H1360\u201370.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"7113_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/BF02111656","volume":"27","author":"E Gnaiger","year":"1995","unstructured":"Gnaiger E, Steinlechner-Maran R, M\u00e9ndez G, Eberl T, Margreiter R. Control of mitochondrial and cellular respiration by oxygen. J Bioenerg Biomembr. 1995;27(6):583\u201396.","journal-title":"J Bioenerg Biomembr"},{"issue":"3","key":"7113_CR11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01062713","volume":"2","author":"Y Li","year":"1995","unstructured":"Li Y, Kloner RA. Is there a gender difference in infarct size and arrhythmias following experimental coronary occlusion and reperfusion? J Thromb Thrombolysis. 1995;2(3):221\u20135.","journal-title":"J Thromb Thrombolysis"},{"key":"7113_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40064-015-0878-x","volume":"4","author":"JS Dow","year":"2015","unstructured":"Dow JS, Bhandari A, Hale SL, Kloner RA. Does sex influence the incidence or severity of reperfusion-induced cardiac arrhythmias? Springerplus. 2015;4:96.","journal-title":"Springerplus."},{"key":"7113_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4419-8997-0_4","volume":"543","author":"E Gnaiger","year":"2003","unstructured":"Gnaiger E. Oxygen conformance of cellular respiration. A perspective of mitochondrial physiology. Adv Exp Med Biol. 2003;543:39\u201355.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"7113_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/ALN.0b013e3182a10e26","volume":"119","author":"M Walsh","year":"2013","unstructured":"Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507\u201315.","journal-title":"Anesthesiology."},{"issue":"11","key":"7113_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrcardio.2017.102","volume":"14","author":"RA Kloner","year":"2017","unstructured":"Kloner RA, Brown DA, Csete M, Dai W, Downey JM, Gottlieb RA, et al. New and revisited approaches to preserving the reperfused myocardium. Nat Rev Cardiol. 2017;14(11):679\u201393.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"7113_CR16","doi-asserted-by":"publisher","first-page":"e005805","DOI":"10.1161\/CIRCINTERVENTIONS.117.005805","volume":"10","author":"RA Kloner","year":"2017","unstructured":"Kloner RA. Mitochondrial protective agents for ischemia\/reperfusion injury. Circ Cardiovasc Interv. 2017;10(9):e005805.","journal-title":"Circ Cardiovasc Interv"},{"key":"7113_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-pharmtox-010715-103335","volume":"57","author":"EJ Lesnefsky","year":"2017","unstructured":"Lesnefsky EJ, Chen Q, Tandler B, Hoppel CL. Mitochondrial dysfunction and myocardial ischemia-reperfusion: implications for novel therapies. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:535\u201365.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"7113_CR18","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.bbabio.2015.12.013","volume":"1857","author":"S Dr\u00f6se","year":"2016","unstructured":"Dr\u00f6se S, Stepanova A, Galkin A. Ischemic A\/D transition of mitochondrial complex I and its role in ROS generation. Biochim Biophys Acta. 2016;1857(7):946\u201357.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"7113_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrd.2018.174","volume":"17","author":"MP Murphy","year":"2018","unstructured":"Murphy MP, Hartley RC. Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov. 2018;17(12):865\u201386.","journal-title":"Nat Rev Drug Discov"},{"key":"7113_CR20","doi-asserted-by":"publisher","unstructured":"Prag HA, Gruszczyk AV, Huang MM, Beach TE, Young T, Tronci L, Nikitopoulou E, Mulvey JF, Ascione R, Hadjihambi A, Shattock MJ, Pellerin L, Saeb-Parsy K, Frezza C, James AM, Krieg T, Murphy MP, Aksentijevi\u0107 D. Mechanism of succinate efflux upon reperfusion of the ischemic heart. Cardiovasc Res. 2020;cvaa148. https:\/\/doi.org\/10.1093\/cvr\/cvaa148. Online ahead of print.","DOI":"10.1093\/cvr\/cvaa148"},{"issue":"3","key":"7113_CR21","doi-asserted-by":"publisher","first-page":"H550","DOI":"10.1152\/ajpheart.00183.2018","volume":"315","author":"RA Kloner","year":"2018","unstructured":"Kloner RA, King KS, Harrington MG. No-reflow phenomenon in the heart and brain. Am J Physiol Heart Circ Physiol. 2018;315(3):H550\u201362.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"14","key":"7113_CR22","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","volume":"67","author":"GW Stone","year":"2016","unstructured":"Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"7113_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1074248418764467","volume":"23","author":"RA Kloner","year":"2018","unstructured":"Kloner RA. No-reflow phenomenon. A new target for therapy of acute myocardial infarction independent of myocardial infarct size. J Cardiovasc Pharmacol Ther. 2018;23(3):273\u20136.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3\u20134","key":"7113_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1074248411405990","volume":"16","author":"RA Kloner","year":"2011","unstructured":"Kloner RA. No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther. 2011;16(3\u20134):244\u201350.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3","key":"7113_CR25","doi-asserted-by":"publisher","first-page":"e001644","DOI":"10.1161\/JAHA.112.001644","volume":"1","author":"RA Kloner","year":"2012","unstructured":"Kloner RA, Hale SL, Dai W, et al. Reduction of ischemia\/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide. J Am Heart Assoc. 2012;1(3):e001644.","journal-title":"J Am Heart Assoc"},{"key":"7113_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10557-016-6695-9","volume":"30","author":"W Dai","year":"2016","unstructured":"Dai W, Cheung E, Alleman RJ, Perry JB, Allen ME, Brown DA, et al. Cardioprotective effects of mitochondria-targeted peptide SBT-20 in two different models of rat ischemia\/reperfusion. Cardiovasc Drugs Ther. 2016;30:559\u201366.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"16","key":"7113_CR27","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/eurheartj\/ehv597","volume":"37","author":"CM Gibson","year":"2016","unstructured":"Gibson CM, Giugliano RP, Kloner RA, Bode C, Tendera M, J\u00e1nosi A, et al. EMBRACE STEMI study: a phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous elamipretide (MTP-131) on reperfusion injury in patients undergoing primary percutaneous intervention. Eur Heart J. 2016;37(16):1296\u2013303.","journal-title":"Eur Heart J"},{"issue":"5","key":"7113_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJMoa071142","volume":"359","author":"C Piot","year":"2008","unstructured":"Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359(5):473\u201381.","journal-title":"N Engl J Med"},{"issue":"11","key":"7113_CR29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373(11):1021\u201331.","journal-title":"N Engl J Med"},{"issue":"5","key":"7113_CR30","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/jcmm.14953","volume":"24","author":"HE B\u00f8tker","year":"2020","unstructured":"B\u00f8tker HE, Cabrera-Fuentes HA, Ruiz-Meana M, Heusch G, Ovize M. Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction. J Cell Mol Med. 2020;24(5):2717\u201329.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"7113_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCRESAHA.112.300627","volume":"113","author":"RA Kloner","year":"2013","unstructured":"Kloner RA. Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res. 2013;113(4):451\u201363.","journal-title":"Circ Res"},{"issue":"5\u20136","key":"7113_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1440-1681.2007.04601.x","volume":"34","author":"Q Xu","year":"2007","unstructured":"Xu Q, Ming Z, Dart AM, Du XJ. Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol. 2007;34(5\u20136):499\u2013507.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"7113_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1476-5381.1976.tb10402.x","volume":"58","author":"AS Clanachan","year":"1976","unstructured":"Clanachan AS, McGrath JC. Effects of ketamine on the peripheral autonomic nervous system of the rat. Br J Pharmacol. 1976;58(2):247\u201352.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"7113_CR34","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1590\/S0102-09352012000400011","volume":"64","author":"C Picollo","year":"2012","unstructured":"Picollo C, Serra AJ, Levy RF, Antonio EL, dos Santos L, Tucci PJF. Hemodynamic and thermoregulatory effects of xylazine-ketamine mixture persist even after the anesthetic stage in rats. Arq Bras Med Vet Zootec. 2012;64(4):860\u20134.","journal-title":"Arq Bras Med Vet Zootec"},{"key":"7113_CR35","first-page":"481","volume":"49","author":"FS Afshar","year":"2005","unstructured":"Afshar FS, Baniadam A, Marashipour SP. Effect of xylazine-ketamine on arterial blood pressure, arterial blood pH, blood gases, rectal temperature, heart and respiratory rates in goats. Bull Vet Inst Pulawy. 2005;49:481\u20134.","journal-title":"Bull Vet Inst Pulawy"},{"issue":"3","key":"7113_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0167-5273(95)02379-B","volume":"50","author":"JM Canty Jr","year":"1995","unstructured":"Canty JM Jr, Smith TP Jr. Modulation of coronary autoregulatory responses by endothelium-derived nitric oxide. Int J Cardiol. 1995;50(3):207\u201315.","journal-title":"Int J Cardiol"},{"issue":"2","key":"7113_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cphy.c160016","volume":"7","author":"AG Goodwill","year":"2017","unstructured":"Goodwill AG, Dick GM, Kiel AM, Tune JD. Regulation of coronary blood flow. Compr Physiol. 2017;7(2):321\u201382.","journal-title":"Compr Physiol"},{"issue":"6","key":"7113_CR38","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1152\/jappl.1988.65.6.2641","volume":"65","author":"I von Planta","year":"1988","unstructured":"von Planta I, Weil MH, von Planta M, Bisera J, Bruno S, Gazmuri RJ, et al. Cardiopulmonary resuscitation in the rat. J Appl Physiol (1985). 1988;65(6):2641\u20137.","journal-title":"J Appl Physiol (1985)"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-07113-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T22:18:45Z","timestamp":1671142725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-07113-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["7113"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-07113-7","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"13 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Aur\u00e9lie Boucard and Bruno Le Grand are employees for OP2 Drugs. Rodrigue Rossignol is a scientific advisor for OP2 Drugs. There are no conflicts of interest for Drs. Dai, Amoedo, Perry, Carreno, Zhao, Brown, and Kloner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}